Graphene 3D Lab Receives Approval for Next Task of R&D-Royalty Agreement with Fortune 500 Manufacturer

Graphene 3D Lab Inc. (TSXV:GGG,OTCQB:GPHBF) announced that it has been approved to move forward with the next task of its research, development and royalty agreement with a Fortune 500 listed manufacturer.
As quoted in the press release:

The Agreement encompasses the development of multi-phased deliverables over the course of approximately a year. For competitive reasons and pursuant to confidentially clauses contained with the Agreement, neither specific research objectives nor the identity of the Fortune 500 manufacturer can be publically disclosed. Upon successful completion of the research phase, and subject to approval by the U.S. Food & Drug Administration, the developed materials will become a part of a consumer retail product.

Graphene 3D Lab Co-Chief Executive Officer, Elena Polyakova, stated:

We are fortunate to have a world leading R&D team in the graphene and nanomaterial field. Meeting or exceeding all of a client’s performance criteria is another example of how we are ideally suited to work with existing manufacturers to assist them with incorporating graphene into their products.

Connect with Graphene 3D Lab Inc. (TSXV:GGG,OTCQB:GPHBF) to receive an Investor Presentation.